4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
Star0
Identification
- Generic Name
- 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
- DrugBank Accession Number
- DB08194
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 181.258
Monoisotopic: 181.067368057 - Chemical Formula
- C8H11N3S
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UHeat shock protein HSP 90-alpha Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as pyranopyridines. These are polycyclic aromatic compounds containing a pyran ring fused to a pyridine ring.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Pyranopyridines
- Sub Class
- Not Available
- Direct Parent
- Pyranopyridines
- Alternative Parents
- Aminopyrimidines and derivatives / Pyridines and derivatives / Heteroaromatic compounds / Dialkylthioethers / Azacyclic compounds / Primary amines / Organopnictogen compounds / Hydrocarbon derivatives
- Substituents
- Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Dialkylthioether / Heteroaromatic compound / Hydrocarbon derivative / Organic nitrogen compound / Organonitrogen compound / Organopnictogen compound
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- AN8UFC8Y2Y
- CAS number
- Not Available
- InChI Key
- ONZWAEXRMZGFAN-UHFFFAOYSA-N
- InChI
- InChI=1S/C8H11N3S/c1-5-6-4-12-3-2-7(6)11-8(9)10-5/h2-4H2,1H3,(H2,9,10,11)
- IUPAC Name
- 4-methyl-5H,7H,8H-thiopyrano[4,3-d]pyrimidin-2-amine
- SMILES
- CC1=NC(N)=NC2=C1CSCC2
References
- General References
- Not Available
- External Links
- PubChem Compound
- 2726820
- PubChem Substance
- 99444665
- ChemSpider
- 2008878
- ZINC
- ZINC000000077255
- PDBe Ligand
- MO8
- PDB Entries
- 3ft5
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 4.41 mg/mL ALOGPS logP 1.04 ALOGPS logP 0.87 Chemaxon logS -1.6 ALOGPS pKa (Strongest Acidic) 16.92 Chemaxon pKa (Strongest Basic) 4.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 51.8 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 52.24 m3·mol-1 Chemaxon Polarizability 19.28 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.996 Blood Brain Barrier + 0.9527 Caco-2 permeable - 0.5238 P-glycoprotein substrate Substrate 0.7196 P-glycoprotein inhibitor I Non-inhibitor 0.8372 P-glycoprotein inhibitor II Non-inhibitor 0.9471 Renal organic cation transporter Inhibitor 0.6368 CYP450 2C9 substrate Non-substrate 0.8164 CYP450 2D6 substrate Non-substrate 0.7877 CYP450 3A4 substrate Non-substrate 0.6768 CYP450 1A2 substrate Non-inhibitor 0.5052 CYP450 2C9 inhibitor Non-inhibitor 0.9011 CYP450 2D6 inhibitor Non-inhibitor 0.8574 CYP450 2C19 inhibitor Non-inhibitor 0.8082 CYP450 3A4 inhibitor Non-inhibitor 0.9746 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7475 Ames test AMES toxic 0.5678 Carcinogenicity Non-carcinogens 0.9615 Biodegradation Not ready biodegradable 0.9956 Rat acute toxicity 2.7520 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7588 hERG inhibition (predictor II) Non-inhibitor 0.5533
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsHeat shock protein HSP 90-alpha
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Tpr domain binding
- Specific Function
- Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Under...
- Gene Name
- HSP90AA1
- Uniprot ID
- P07900
- Uniprot Name
- Heat shock protein HSP 90-alpha
- Molecular Weight
- 84659.015 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:29 / Updated at June 12, 2020 16:52